Show simple item record

An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

dc.contributor.authorCoskun, H. S.
dc.contributor.authorAykan, N. F.
dc.contributor.authorSevinc, A.
dc.contributor.authorSanli, U. S.
dc.contributor.authorKara, I. O.
dc.contributor.authorDane, F.
dc.contributor.authorOzgurdal, K.
dc.contributor.authorYalcin, S.
dc.contributor.authorBenekli, M.
dc.contributor.authorYucel, I.
dc.contributor.authorOzkan, M.
dc.contributor.authorEvrensel, T.
dc.date.accessioned2021-03-04T19:54:30Z
dc.date.available2021-03-04T19:54:30Z
dc.identifier.citationDane F., Ozgurdal K., Yalcin S., Benekli M., Aykan N. F. , Yucel I., Ozkan M., Evrensel T., Sevinc A., Coskun H. S. , et al., "An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)", ESMO 17th World Congress on Gastrointestinal Cancer, Barcelona, İspanya, 1 - 04 Temmuz 2015, cilt.26
dc.identifier.othervv_1032021
dc.identifier.otherav_920c3e8c-dde6-46a7-8629-63c73b6e2a84
dc.identifier.urihttp://hdl.handle.net/20.500.12627/98510
dc.identifier.urihttps://doi.org/10.1093/annonc/mdv233.253
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleAn open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
dc.typeBildiri
dc.contributor.departmentMarmara Üniversitesi , ,
dc.identifier.volume26
dc.contributor.firstauthorID147187


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record